Fidelis Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Buy |
5,291
+575
| +12% | +$63.4K | 0.05% | 239 |
|
|
2025
Q1 | $487K | Buy |
4,716
+7
| +0.1% | +$722 | 0.05% | 251 |
|
|
2024
Q4 | $463K | Buy |
4,709
+215
| +5% | +$21.2K | 0.05% | 266 |
|
|
2024
Q3 | $392K | Buy |
4,494
+268
| +6% | +$23.4K | 0.05% | 274 |
|
|
2024
Q2 | $313K | Buy |
4,226
+1,201
| +40% | +$88.9K | 0.04% | 280 |
|
|
2024
Q1 | $222K | Buy |
3,025
+500
| +20% | +$36.6K | 0.03% | 337 |
|
|
2023
Q4 | $205K | Buy |
+2,525
| New | +$205K | 0.05% | 313 |
|